Abstract Submission Information

As you prepare your work for presentation at the AMP 2017 Annual Meeting, consider that the theme this year is, "Where Molecular Leads Medicine to Best Patient Care.” Exciting new work presented in abstract form will round out our relevant and comprehensive program. The Program Committee recognizes abstract submissions as a cutting edge indicators of new directions in our field. The data presented in abstracts will lead to new diagnostic markers and methodology that will positively impact further research, the clinical laboratory, and patient care. Some of the most enthusiastic discussion and productive collaborations begin at the poster sessions and continue throughout the meeting and beyond. We look forward to your submissions and to seeing you in Salt Lake City!

On behalf of the 2017 AMP Program Committee,
Daniel E. Sabath, MD, PhD (Chair)

All participants at the AMP 2017 Annual Meeting are invited to submit abstracts of original studies related to molecular pathology and diagnostics.

QUICK LINKS / RESOURCES

Eligibility: Only AMP Regular Members are eligible to submit abstracts. Associate Members (Trainees) and non-members must have a Regular Member sponsor their abstract. The Regular Member does not need to be an author on the abstract. If you are not a Regular Member of AMP, join now to submit your abstract today. You may submit an abstract and apply to join AMP on the same day, up to and through the submission deadline. However, we encourage you to join AMP in advance of the deadline!

Submission Categories:

• Genetics

• Hematopathology

• Infectious Diseases

• Informatics

• Solid Tumors

• Technical Topics

• Other (Education, etc.)*

*Abstract submissions in the "Other (Education, etc.)" topic category may include descriptions of novel educational approaches, innovative programs, pioneering technologies, etc. As with other abstract submissions, these abstract submissions must demonstrate the scientific method, i.e., describe the methodology and data collection, identify how to measure, analyze, and report outcomes, and provide conclusions. All submitted abstracts will be reviewed with the same criteria (see below).

Deadlines 

Submission: Complete abstracts must be submitted online no later than 11:59 pm ET on Wednesday, May 31, 2017. All abstract submissions must be complete and finalized before this time and date - NO EXCEPTIONS. The final abstract submission step is not complete until you have clicked the "Finalize and Save" button. Only the Corresponding Author will receive a confirmation email only after your abstract has been successfully finalized and submitted. Abstracts that are in process but not finalized after the deadline will not be considered for acceptance and/or awards.

Notification: The Corresponding Author will be notified by email no later than Monday, July 17, 2017. Accepted abstracts will be published in the November 2017 issue of The Journal of Molecular Diagnostics (JMD) (see "Eligibility for Publication" section). Abstracts that are not eligible for publication in JMD, i.e., have been submitted to another publication or to another meeting that occurs before November 2017, will be rejected. Abstracts may be withdrawn until 11:59 pm ET on Tuesday, August 1, 2017.

Embargo: The research presented as posters at the AMP Annual Meeting from the abstracts published in the November issue of JMD is embargoed until the first day of poster presentations at the Annual Meeting.

Poster Presentation: First authors of accepted abstracts are expected to register as an attendee and present posters at the Annual Meeting summarizing their studies. All authors of abstracts must adhere to the AMP Scientific Integrity Policy.

FREQUENTLY ASKED QUESTIONS

Abstract Format Requirements

Abstracts that are not submitted properly will receive an administrative reject and will not be reviewed.

1. Abstracts must be submitted properly. The online system is a database, with data fields (title, author 1, author 2, author 3, etc) that are used to generate the published abstracts. Therefore, pay careful attention to the submission instructions and to the submission process, including spelling, capitalization, author names, etc.

2. All abstracts must include the required headers listed below; each header must be included in your text:

   • Introduction: a brief discussion of the background or rationale of the study and/or the question addressed

   • Methods: the experimental approach, materials, and methods used in the study

   • Results: the data and results obtained in the study

   • Conclusions: the conclusions and/or implications of the results

3. Abstract Limits:

   • Number of authors: 30

   • Abstract Title: 200 characters

   • Abstract Content: 2800 characters (with spaces and including section headers)

4. You may include formatting (e.g. italicizing genes), Greek letters and special symbols, e.g. °C (degree sign), superscripts, etc. Data must be reported in narrative format in the abstract submission; tables may be included in your poster.

5. Only AMP Regular Members are eligible to submit abstracts. Associate Members and non-members must have a Regular Member sponsor their abstract. If you are not a Regular member of AMP, join now to submit your abstract today. You may submit an abstract and apply to join AMP on the same day, up to and through the submission deadline. However, we encourage you to join AMP in advance of the deadline!

6. Your abstract will be rated using four criteria:

   • Originality and Clarity

   • Novelty

   • Scientific Merit/Rigor

   • Appropriate Conclusions

7. Summary: Grounds for abstract rejection are:

   • Failure to follow directions in 1-5.

   • Abstracts that are not eligible for publication in JMD, i.e., have been submitted to another publication or to another meeting that occurs prior to November 2017.

   • Abstract contains no scientific data and/or has only a promise of future data.

   • Duplicate abstracts are submitted.

   • Sponsor is not an AMP Regular member.

   • Sponsor or any author violated any of the AMP rules for presentation at a previous meeting, e.g., the authors failed to present a poster without notifying AMP prior to the meeting.

The five most common reasons for rejection are:

• Previously presented/published
• Poor organization/clarity
• Does not provide novel information
• Insufficient scientific quality
• Insufficient data

Author Information

1. The Corresponding (Submitting) Author is the individual who submits the abstract and is the contact person for all correspondence from AMP. The Corresponding Author does not need to be the senior author. The Corresponding Author has the following responsibilities:
   • verifies that all authors agree to the publication of the abstract in JMD.
   • verifies that all authors agree, and any supervisors have given permission, to the presentation of a scientific poster at the annual meeting.
   • responsible for notifying all other authors of acceptance, rejection, scheduling and any other information provided by AMP.
   • responsible for notifying the Presenting (First) Author of the AMP Rules for Poster Display and any other information provided by AMP. Young Investigator Award applicants are responsible for notifying their faculty mentors of the additional rules for poster display for award (see "AWARDS INFORMATION" section).
   • responsible for compliance with the AMP Scientific Integrity Policy.
2. The First Author is also considered the Presenting Author (who may be the Corresponding Author) and has the following responsibilities:
   • expected to register for the Annual Meeting and attend the poster at the assigned time period to discuss the study and answer questions. If the Presenting Author is unable to attend the Annual Meeting to present the poster, every effort should be made to arrange for one of the other authors to present the poster. Both AMP (ampeducation@amp.org) and the Annual Meeting Program Chair, Dr. Daniel Sabath (dsabath@uw.edu) must be notified. Failure to defend one's study by not attending the poster during the assigned time period is a violation of the AMP Scientific Integrity Policy and may result in forfeiture of future abstract submission privileges.
   • expected to ensure that the abstract poster conforms to the Rules for Poster Display at the Annual Meeting (i.e., poster display size, format, and schedule).
3. Please note that accepted abstracts that have not been previously published as either an abstract or a paper will be eligible for publication in the November 2017 issue of JMD. Abstracts that have been previously published or that are under consideration as an abstract for another meeting that occurs prior to November 2017 will be rejected.
4. IMPORTANT: A disclosure report of relevant financial relationships is required for each author of a submitted abstract. Therefore, we recommend that you collect disclosure information from each author before you begin your abstract submission in order to expedite the online entry process. Each time you add an author's name during the online submission process, you will be asked to complete a disclosure report that is specific to that author. Employees of commercial entities should disclose employment in this section. Noting the company name in the Author Information field is not sufficient.